Experimental drugs from Roche Holding AG and Eli Lilly & Co have been selected for a global Alzheimer's disease prevention trial, and a second Lilly drug is being considered for inclusion in the study
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment